Related Experiment Video
Updated: Mar 23, 2026
14:18
Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
Published on: October 13, 2023
2.0K
Sinigrin and Its Therapeutic Benefits
Anisha Mazumder1, Anupma Dwivedi2, Jeanetta du Plessis3
1Centre of Excellence for Pharmaceutical Sciences, North-West University, Private Bag X6001, Potchefstroom 2520, South Africa. anishamajumdar@gmail.com.
Molecules (Basel, Switzerland)
|April 5, 2016
Summary
Sinigrin, a compound found in mustard seeds and broccoli, exhibits potential therapeutic benefits including anti-cancer and anti-inflammatory effects. Further research is needed to fully understand its medicinal properties and mechanisms of action.
Area of Science:
- Phytochemistry
- Pharmacology
- Natural Products
Background:
- Sinigrin, an aliphatic glucosinolate, is abundant in Brassicaceae plants like broccoli and mustard seeds.
- Mustard has a long history of culinary and medicinal use, recognized in Ayurvedic traditions.
- Sinigrin is known for various pharmacological activities, including anti-cancer, antibacterial, and antioxidant properties.
Purpose of the Study:
- To review the known therapeutic activities of sinigrin.
- To summarize current knowledge on the medicinal benefits of this phytocompound.
- To highlight the need for further research into sinigrin's biological activities and mechanisms.
Main Methods:
- Literature review of existing studies on sinigrin.
- Compilation of reported pharmacological and therapeutic effects.
- Analysis of traditional medicinal uses.
Main Results:
- Sinigrin demonstrates a range of biological activities: anti-cancer, antibacterial, antifungal, antioxidant, anti-inflammatory, wound healing, and biofumigation.
- Traditional texts document the medicinal applications of mustard, indicating historical recognition of sinigrin's benefits.
- Current data on sinigrin's biological activities is limited.
Conclusions:
- Sinigrin is a promising phytocompound with diverse potential therapeutic applications.
- Further investigation is crucial to elucidate the molecular mechanisms underlying sinigrin's beneficial effects.
- Comprehensive studies are required to fully validate and explore the therapeutic potential of sinigrin.
Related Concept Videos
01:06Oral Hypoglycemic Agents: Glinides
926
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
926
01:30Inhibitors of Viral Protein Synthesis
4
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
4
01:24Glucagon-like Receptor Agonists
1.3K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.3K
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
591
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
591
01:23Dipeptidyl Peptidase 4 Inhibitors
986
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
986
01:26Cholinergic Antagonists: Therapeutic Uses
1.7K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.7K